Dorry Lidor Segev
Johns Hopkins University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Diabetes Treatment and Management
Strong evidence · 1 supporting paper · latest 2026
Renal Transplantation Outcomes and Treatments
Solid evidence · 2 supporting papers · latest 2026
Organ Donation and Transplantation
Solid evidence · 1 supporting paper · latest 2026
Immune responses and vaccinations
Supporting evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Supporting evidence · 1 supporting paper · latest 2026
Dialysis and Renal Disease Management
Supporting evidence · 1 supporting paper · latest 2026
Bariatric Surgery and Outcomes
Supporting evidence · 1 supporting paper · latest 2026
Diabetes, Cardiovascular Risks, and Lipoproteins
Supporting evidence · 1 supporting paper · latest 2026
Publications (3)
Trends in GLP ‐1 Receptor Agonist Prescribing Without an Apparent FDA ‐Approved Indication
2026DOI
Early Changes in Kidney Transplantation following Implementation of the Increasing Organ Transplant Access Model
2026DOI
Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Johns Hopkins University
Source: ScienceWe Extractor · retrieved 2026-09-27